FDA Warning Letter on Injection Lypolysis
On April 7, 2010, the FDA issued warning letters to six U.S.-based medical spas and a company in Brazil for making false or misleading statements about drugs they claim will eliminate fat in a procedure called “lipodissolve.” The drugs used in this procedure have not been evaluated or approved by the FDA.
For complete information, including links to the FDA’s letters, its Q&A, and a consumer article, please read the FDA news release.
The guidelines suggested here are not rules, do not constitute legal advice, and do not ensure a successful outcome. The ultimate decision regarding the appropriateness of any treatment must be made by each health care provider in light of all circumstances prevailing in the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.